Liqin Xu（xuliqin@genomics.cn）。Dr. Xu has been working on genomics related technology research and development since 2012 and is currently leading Central Lab for Application Development in MGI Germany. Dr. Xu supervised/participated multiple research projects on single cell, oncology and gut microbiome, and received more than five million CNY governmental funding.
研究方向：Single-cell omics, Microbiology
现任岗位：MGI, EU&AF
教育背景：PhD, Bioengineering, Technical University of Denmark
参与项目:
1.Human single cell Atlas research.
2.Gut microbiome of Cancer patients that accept immunotherapy.
3.Development of embryo liver revealed by single cell RNA sequencing.
论文:
1.Embryonic liver developmental trajectory revealed by single-cell RNA sequencing in the Foxa2eGFP mouse
2.Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma
3.Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients
专利:
1.METHODFORCONSTRUCTINGSINGLE CELL SEQUENCING LIBRARYAND USE THEREOF
2.一种单细胞DNA文库的构建方法
Research Gate 链接:
https://www.researchgate.net/profile/Liqin-Xu
Google Scholar链接:
https://scholar.google.com/citations?user=DpxUKgQAAAAJ&hl=zh-CN
